Delaney Dennis R Has $1.53 Million Position in CVS Health Co. (NYSE:CVS)

Delaney Dennis R cut its position in shares of CVS Health Co. (NYSE:CVS) by 19.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,141 shares of the pharmacy operator’s stock after selling 4,747 shares during the period. Delaney Dennis R’s holdings in CVS Health were worth $1,527,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Atticus Wealth Management LLC increased its stake in shares of CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the last quarter. USA Financial Formulas boosted its holdings in shares of CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. bought a new stake in shares of CVS Health during the 4th quarter worth about $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health during the 4th quarter worth about $34,000. Finally, Steph & Co. boosted its holdings in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS stock traded up $0.68 during trading on Thursday, reaching $58.21. 7,361,335 shares of the company were exchanged, compared to its average volume of 11,828,175. The company has a 50-day moving average of $58.14 and a two-hundred day moving average of $69.03. The company has a market capitalization of $73.08 billion, a price-to-earnings ratio of 10.23, a P/E/G ratio of 0.54 and a beta of 0.52. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The company had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.20 earnings per share. As a group, equities analysts predict that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.57%. The ex-dividend date is Monday, July 22nd. CVS Health’s dividend payout ratio (DPR) is currently 46.75%.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Edward J. Ludwig purchased 1,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The stock was purchased at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the transaction, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.24% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of several research analyst reports. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $58.00 target price on shares of CVS Health in a report on Wednesday, June 12th. Leerink Partnrs downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 1st. Barclays cut their price objective on shares of CVS Health from $78.00 to $63.00 and set an “equal weight” rating for the company in a report on Thursday, May 2nd. Baird R W raised shares of CVS Health to a “hold” rating in a report on Thursday, May 30th. Finally, Piper Sandler boosted their price objective on shares of CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, March 15th. Eleven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $75.05.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.